Get Johnson & Johnson (JNJ:NYSE) real-time stock quotes, news, price and financial information from CNBC.
Get Johnson & Johnson (JNJ:NYSE) real-time stock quotes, news, price and financial information from CNBC.
JNJ:CA Dividends Dividend Yield (TTM) 3.16% Annual Payout (TTM) $0.65 Payout Ratio - 5 Year Growth Rate (CAGR) - Years of Growth 0 Years Latest Announced Dividend $0.16 Ex-Dividend Date 11/26/2024 Payout Date 12/17/2024 Frequency Quarterly More On Dividends » JNJ:CA Ownership JNJ...
As a reminder, on August 23rd, 2023, Johnson & Johnson announced the final results of the exchange offer and completion of the separation of Kenvue Inc. Unless otherwise stated, the financial results and guidance highlighted today reflect the continuing operations of Johnson & Johnson. We will r...
and progression of our multiple myeloma portfolio, which Joaquin referenced. Investment in R&D remains a top priority to support long-term growth and value creation. Our second priority is our commitment to dividends. 2022 marks the 60th consecutive year in which we increased our annual dividend. ...
In M&A, as we previously announced, we strengthened our consumer business with the acquisition of DR. CI:LABO. In addition to R&D and M&A spending, we also used cash in the quarter to continue returning value to shareholders in the form of dividends and buybacks. We paid a quar...
picks dividends dividend stock news reits dividend ideas dividend strategy dividend quick picks editors' picks analysis by sector energy communication services real estate consumer staples tech basic materials healthcare consumer utilities financials industrials stock comparison tools faang stocks gold etfs ...
have year to date, over $13 billion. Also very proud of the fact that we've been able to distribute nearly $11 billion to shareholders through the form of our dividend program, as well as the repurchase program that was announced just mid last month. So we feel really good on t...
Fauci suggested that a decision to resume JNJ vaccinations would likely be taken when the CDC meets this Friday, and on Tuesday, the European Medicine Agency ruled that the risk benefit profile of JNJ's vaccine "remains positive" and announced that shipments would resume. A "handful" of new ...